Since the first edition was released in 1999, the Pocket Guide to Urology has become one of the most popular urology texts. Over 35,000 copies of the Pocket Guide to Urology have been printed and distributed worldwide (over 45 countries on 6 continents). The 6th edition is currently for sale.
The 6th edition of the Pocket Guide to Urology is a comprehensive evidence-based reference book that emphasizes clinical guidelines, consensus statements, and landmark studies. Information is compiled and is presented in a thorough, organized, and logical format. Each chapter contains detailed references.
Updates/additions to the 6th edition include:
NCCN β 2021 guidelines
AUA β most recent guidelines
EAU β 2021 guidelines
Many other recent guidelines including CDC, WHO, Infectious Diseases Society of America (ISDA),
American Association for the Surgery of Trauma (AAST), American College of Radiology (ACR),
European Society of Urogenital Radiology, American College of Obstetricans and Gynecologists,
International Continence Society (ICS), etc.
Updates and addition of landmark studies.
New medications: Jatenzo, Vibegron, Lumasiran, Relugolix, jelmyto, PARP inhibitors (Olaparib, Rucaparib),
PDL/PDL1 inhibitors (Pembrolizumab, Erdafitinib), etc.
Updates of all flowsheets and diagrams to reflect the most recent guidelines and data.
Update on Bozniak classifiation
PET/CT information including flucyclovine and PSMA.
Expanded section on MRI, including MRI guided prostate biopsy, MRI for cancer surveillance, etc.
Expanded on genetic risks for the various cancers, somatic & germline tests, and testing guidelines.
More info on molecular testing for prostate cancer: decipher, oncotype dx, prolaris, etc.
Newest studies on salvage and adjuvant XRT after RP for prostate cancer
Newer BPH treatments (acquablation, resume, etc).
Updates and additions to almost every chapter.